Press Releases about Adc Therapeutics Sa
![](https://mms.businesswire.com/media/20221031005170/en/1618268/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220921005889/en/1579357/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220916005045/en/1573723/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220914005737/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://mms.businesswire.com/media/20220913006308/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://mms.businesswire.com/media/20220906005337/en/1561562/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220815005541/en/1544242/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220809005173/en/1537957/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220802005270/en/1531156/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220727005171/en/1525225/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220720005091/en/1518155/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220711005186/en/1508675/4/Overland_Pharma_logo.jpg)
![](https://mms.businesswire.com/media/20220707005788/en/1507708/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220701005047/en/1502570/4/Jean-Pierre_Bizzari_5x7.jpg)
![](https://mms.businesswire.com/media/20220629005089/en/1499348/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220613005176/en/1483675/5/David_Gilman.jpg)
![](https://mms.businesswire.com/media/20220610005073/en/1482681/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220601005177/en/1471617/5/ADCT_4C_TM.jpg)
From ADC Therapeutics SA
Via Business Wire
![](https://mms.businesswire.com/media/20220512005635/en/1453640/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220509005297/en/1447320/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20220509005267/en/1447253/5/Ameet_Mallik.jpg)
![](https://mms.businesswire.com/media/20220504005296/en/1180141/5/ADC_Therapeutics_logo.jpg)
![](https://mms.businesswire.com/media/20220503005540/en/1180141/5/ADC_Therapeutics_logo.jpg)
![](https://mms.businesswire.com/media/20220404005297/en/1180141/5/ADC_Therapeutics_logo.jpg)
![](https://mms.businesswire.com/media/20220317005065/en/1180141/5/ADC_Therapeutics_logo.jpg)
![](https://mms.businesswire.com/media/20220224005180/en/1180141/5/ADC_Therapeutics_logo.jpg)
![](https://mms.businesswire.com/media/20220217005208/en/1180141/5/ADC_Therapeutics_logo.jpg)
ADC Therapeutics Releases its Inaugural Environmental, Social and Governance Report
February 17, 2022
From ADC Therapeutics SA
Via Business Wire
![](https://mms.businesswire.com/media/20220208005336/en/1180141/5/ADC_Therapeutics_logo.jpg)
From ADC Therapeutics SA
Via Business Wire
![](https://mms.businesswire.com/media/20220202005098/en/1180141/5/ADC_Therapeutics_logo.jpg)
ADC Therapeutics to Participate in Guggenheim Oncology Conference
February 02, 2022
From ADC Therapeutics SA
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.